Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up

被引:21
|
作者
Hajili, Turkan [1 ]
Ohlmann, Carsten H. [1 ]
Linxweiler, Johannes [1 ]
Niklas, Christina [1 ]
Janssen, Martin [1 ]
Siemer, Stefan [1 ]
Stoeckle, Michael [1 ]
Saar, Matthias [1 ]
机构
[1] Saarland Univ, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
关键词
inductive androgen deprivation; inoperable high-risk prostate cancer; prostate-specific antigen nadir; radical prostatectomy; #pcsm; #ProstateCancer; NEOADJUVANT HORMONAL-THERAPY; HIGH-RISK; PHASE-II; MEN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1111/bju.14393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. Patients and MethodsA monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). ResultsWe retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150months was 82%. ConclusionsSurgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [21] Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up
    Tomás Merino
    Ignacio F San Francisco
    Pablo A Rojas
    Piero Bettoli
    Álvaro Zúñiga
    Pelayo Besa
    BMC Cancer, 13
  • [22] Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow-up
    Bianchi, Lorenzo
    Gandaglia, Giorgio
    Fossati, Nicola
    Larcher, Alessandro
    Pultrone, Cristian
    Turri, Filippo
    Selli, Cesare
    de Groote, Ruben
    de Naeyer, Geert
    Borghesi, Marco
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Briganti, Alberto
    Montorsi, Francesco
    Mottrie, Alexandre
    MINERVA UROLOGICA E NEFROLOGICA, 2019, 71 (01) : 38 - 46
  • [23] Prostate cancer-related anxiety in long-term survivors after radical prostatectomy
    Meissner, Valentin H.
    Herkommer, Kathleen
    Marten-Mittag, Birgitt
    Gschwend, Jurgen E.
    Dinkel, Andreas
    JOURNAL OF CANCER SURVIVORSHIP, 2017, 11 (06) : 800 - 807
  • [24] Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korea
    Suh, Jungyo
    Jung, Jae Hyun
    Jeong, Chorok
    Lee, Sang Eun
    Lee, Eunsik
    Ku, Ja Hyeon
    Kim, Hyeon Hoe
    Kwak, Cheol
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (03) : 269 - 276
  • [25] HIGH FAILURE RATE ASSOCIATED WITH LONG-TERM FOLLOW-UP OF NEOADJUVANT ANDROGEN DEPRIVATION FOLLOWED BY RADICAL PROSTATECTOMY FOR STAGE-C PROSTATIC-CANCER
    CHER, ML
    SHINOHARA, K
    BRESLIN, S
    VAPNEK, J
    CARROLL, PR
    BRITISH JOURNAL OF UROLOGY, 1995, 75 (06): : 771 - 777
  • [26] The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
    Antonarakis, Emmanuel S.
    Feng, Zhaoyong
    Trock, Bruce J.
    Humphreys, Elizabeth B.
    Carducci, Michael A.
    Partin, Alan W.
    Walsh, Patrick C.
    Eisenberger, Mario A.
    BJU INTERNATIONAL, 2012, 109 (01) : 32 - 39
  • [27] Long-term follow-up after triple treatment of prostate cancer stage pT3
    Schelin, Sonny
    Madsen, Mikael
    Palmqvist, Elisabeth
    Makela, Erik
    Klintenberg, Claes
    Aus, Gunnar
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (03): : 186 - 191
  • [28] Long-term follow-up of radiotherapy for prostate cancer
    Swanson, GP
    Riggs, MW
    Earle, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02): : 406 - 411
  • [29] Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years
    Francolini, G.
    Loi, M.
    Di Cataldo, V
    Detti, B.
    Stocchi, G.
    Masi, L.
    Doro, R.
    Scoccimarro, E.
    Bellini, C.
    Aquilano, M.
    Allegra, A. G.
    Peruzzi, A.
    Guerrieri, B.
    Morelli, I
    Valzano, M.
    Ciccone, L. P.
    Salvestrini, V
    Desideri, I
    Livi, L.
    CLINICAL ONCOLOGY, 2022, 34 (01) : 50 - 56
  • [30] LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF TRIMODALITY THERAPY OF WEEKLY PACLITAXEL, RADIATION, AND ANDROGEN DEPRIVATION IN HIGH-RISK PROSTATE CANCER WITH OR WITHOUT PRIOR PROSTATECTOMY
    Hussain, Arif
    Wu, Yin
    Mirmiran, Alireza
    DiBiase, Steven
    Goloubeva, Olga
    Bridges, Benjamin
    Mannuel, Heather
    Engstrom, Christine
    Dawson, Nancy
    Amin, Pradip
    Kwok, Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 167 - 174